Literature DB >> 31715606

The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting.

Nahla M Badr1,2, Fedor Berditchevski1, Abeer M Shaaban3,4,5.   

Abstract

The prognostic value of the immune cell infiltrate in the breast carcinoma microenvironment is still uncertain. We reviewed published articles analysing the infiltration of inflammatorycells in the microenvironment of breast carcinoma. Data revealed the importance of infiltration of these immune cells in the prognosis of breast carcinoma, particularly the triple-negative and HER2-positive phenotypes. Tumour-infiltrating lymphocytes and their subtypes play a fundamental role in predicting the pathological complete response (pCR) to neoadjuvant chemotherapy. More research aiming to dissect a complex network of communication between cancer cells and other cellular components of the tumour microenvironment is necessary to develop more effective therapeutic approaches.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Breast carcinoma; Neoadjuvant chemotherapy; Pathological complete response; Tumour-infiltrating dendritic cells; Tumour-infiltrating lymphocytes; Tumour-infiltrating macrophages; Tumour-infiltrating neutrophils

Mesh:

Substances:

Year:  2019        PMID: 31715606     DOI: 10.1159/000504055

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  7 in total

1.  CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients.

Authors:  Carlos López; Ramón Bosch; Anna Korzynska; Marcial García-Rojo; Gloria Bueno; Joan Francesc García-Fontgivell; Salomé Martínez González; Andrea Gras Navarro; Esther Sauras Colón; Júlia Casanova Ribes; Lukasz Roszkowiak; Daniel Mata; Meritxell Arenas; Junior Gómez; Albert Roso; Marta Berenguer; Silvia Reverté-Villarroya; Montserrat Llobera; Jordi Baucells; Marylène Lejeune
Journal:  Breast Cancer       Date:  2022-02-08       Impact factor: 4.239

2.  Peripheral Blood Mononuclear Cell Populations Correlate with Outcome in Patients with Metastatic Breast Cancer.

Authors:  Anna-Maria Larsson; Olle Nordström; Alexandra Johansson; Lisa Rydén; Karin Leandersson; Caroline Bergenfelz
Journal:  Cells       Date:  2022-05-13       Impact factor: 7.666

3.  Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer.

Authors:  Rashmi Verma; Andrew M Hanby; Kieran Horgan; Eldo T Verghese; Milene Volpato; Clive R Carter; Thomas A Hughes
Journal:  Breast Cancer Res Treat       Date:  2020-06-23       Impact factor: 4.872

Review 4.  Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications.

Authors:  Maria Vittoria Dieci; Federica Miglietta; Valentina Guarneri
Journal:  Cells       Date:  2021-01-23       Impact factor: 6.600

5.  The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications.

Authors:  Catarina Nascimento; Andreia Gameiro; Jorge Correia; João Ferreira; Fernando Ferreira
Journal:  Cells       Date:  2022-08-18       Impact factor: 7.666

6.  Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer.

Authors:  Hesham Elghazaly; Hope S Rugo; Hamdy A Azim; Sandra M Swain; Banu Arun; Matti Aapro; Edith A Perez; Benjamin O Anderson; Frederique Penault-Llorca; Pierfranco Conte; Nagi S El Saghir; Cheng-Har Yip; Marwan Ghosn; Philip Poortmans; Mohamed A Shehata; Armando E Giuliano; Jessica W T Leung; Valentina Guarneri; Joseph Gligorov; Bahadir M Gulluoglu; Hany Abdel Aziz; Mona Frolova; Mohamed Sabry; Charles M Balch; Roberto Orecchia; Heba M El-Zawahry; Sana Al-Sukhun; Khaled Abdel Karim; Alaa Kandil; Ruslan M Paltuev; Meteb Foheidi; Mohamed El-Shinawi; Manal ElMahdy; Omalkhair Abulkhair; Wentao Yang; Adel T Aref; Joaira Bakkach; Nermean Bahie Eldin; Hagar Elghazawy
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

Review 7.  Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More.

Authors:  Yang Li; Wenfang Miao; Doudou He; Siqi Wang; Jianjuan Lou; Yanni Jiang; Shouju Wang
Journal:  Front Bioeng Biotechnol       Date:  2021-06-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.